Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 5609

Sort by

Sort Order Select

Journal Articles

Progressive NK-cell dysfunction and ILC imbalance favor immune evasion in multiple myeloma

Maria Teresa Bilotta, Antonio Giovanni Solimando, Vanessa Desantis, Lucia Di Marzo, Andrea Sabatini, Sergio Forcelloni, Alessandro Andriano, Arcangelo Morizio, Antonella Argentiero, Roberto Ria, Linda Quatrini, Lorenzo Moretta, Paola Vacca, Nicola Tumino

Blood Adv (2025) 9 (24): 6246–6251.

https://doi.org/10.1182/bloodadvances.2025016659

Published: 2025

Includes: Supplemental data

Journal Articles

A new sUSPect in T-ALL risk stratification

Stephanie J. Si Lim, David T. Teachey

Blood Adv (2025) 9 (24): 6467–6468.

https://doi.org/10.1182/bloodadvances.2025017870

Published: 2025

Journal Articles

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study

Blood Adv (2025) 9 (24): 6292–6304.

https://doi.org/10.1182/bloodadvances.2024015787

Published: 2025

Includes: Supplemental data

Journal Articles

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis

Samira Glaeser-Khan, Satoko Ito, Manraj Sra, Rhys Richmond, Robert D. Bona, Harlan M. Krumholz, Stacy E. Croteau, Adam Cuker, George Goshua

Blood Adv (2025) 9 (24): 6237–6245.

https://doi.org/10.1182/bloodadvances.2025016822

Published: 2025

Includes: Supplemental data

Journal Articles

SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma

Rudra Prasad Dutta, Heng-Huan Lee, Violetta V. Leshchenko, Ravi Prakash Shukla, Fangfang Yan, Yang Liu, H. Ümit Kaniskan, Xing Qiu, Jian Jin, Lapo Alinari, Michael Wang, Samir Parekh

Blood Adv (2025) 9 (24): 6267–6278.

https://doi.org/10.1182/bloodadvances.2025016801

Published: 2025

Includes: Supplemental data

Journal Articles

Fifteen years of use of functional imaging in multiple myeloma: where we started and where we are going

Elena Zamagni, Marco Talarico

Blood Adv (2025) 9 (24): 6252–6266.

https://doi.org/10.1182/bloodadvances.2024015686

Published: 2025

Journal Articles

Monoclonal gammopathy defines distinct clinical subsets in chronic lymphocytic leukemia across therapeutic eras

Yuting Yan, Bolin Yuan, Tonglu Qiu, Guoqiang Liu, Weihao Chen, Tingyu Wang, Ying Yu, Wenjie Xiong, Gang An, Dehui Zou, Jianyong Li, Liang Wang, Shuhua Yi

Blood Adv (2025) 9 (24): 6279–6291.

https://doi.org/10.1182/bloodadvances.2025017057

Published: 2025

Includes: Supplemental data

Journal Articles

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

Blood Adv (2025) 9 (24): 6314–6325.

https://doi.org/10.1182/bloodadvances.2025017084

Published: 2025

Includes: Supplemental data

Journal Articles

Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation

Bhavna Bhasin-Chhabra, Tao Wang, John E. Levine, Shalini Shenoy, Miguel-Angel Perales, Asad Bashey, Hershel Raff, Wael Saber

Blood Adv (2025) 9 (24): 6394–6401.

https://doi.org/10.1182/bloodadvances.2025016655

Published: 2025

Includes: Supplemental data

Journal Articles

Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL

Malte Roerden, Luca Hensen, Britta Besemer, Friederike Schwartz, Kristina Reuss, Alisha Weiss-Haug, Lennart Harland, Franziska Ginsberg, Christoph Faul, Wolfgang Bethge, Claudia Lengerke

Blood Adv (2025) 9 (24): 6340–6344.

https://doi.org/10.1182/bloodadvances.2025017770

Published: 2025

Journal Articles

A novel isoform of tensin-1 promotes actin filament assembly for efficient erythroblast enucleation

Arit Ghosh, Megan Coffin, Dimitri M. Diaz, Sarah Barndt, Vincent P. Schulz, Patrick G. Gallagher, Su Hao Lo, Velia M. Fowler

Blood Adv (2025) 9 (24): 6356–6369.

https://doi.org/10.1182/bloodadvances.2025016100

Published: 2025

Includes: Supplemental data

Journal Articles

Emicizumab in infants: not just cost-effective but mandatory

Guy Young

Blood Adv (2025) 9 (24): 6354–6355.

https://doi.org/10.1182/bloodadvances.2025017871

Published: 2025

Journal Articles

Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis

Blood Adv (2025) 9 (24): 6491–6501.

https://doi.org/10.1182/bloodadvances.2025016117

Published: 2025

Includes: Supplemental data

Journal Articles

Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel

Akshay Sharma, Franco Locatelli, Monica Bhatia, Lyndsay Molinari, Markus Y. Mapara, Robert I. Liem, Laurence Dedeken, Donna Wall, Michael J. Eckrich, Kevin H. M. Kuo, Wally Smith, Suzan Imren, Puja Kohli, Nanxin Li, Tina Liu, Jaime Rubin, William Hobbs, Stephan A. Grupp, Haydar Frangoul

Blood Adv (2025) 9 (24): 6481–6490.

https://doi.org/10.1182/bloodadvances.2025016701

Published: 2025

Includes: Supplemental data

Journal Articles

Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcel

Blood Adv (2025) 9 (24): 6502–6510.

https://doi.org/10.1182/bloodadvances.2025016702

Published: 2025

Includes: Supplemental data

Journal Articles

USP7 alterations are associated with a poor survival in pediatric T-cell acute lymphoblastic leukemia

Unai Illarregi, Angela Gutierrez-Camino, Ricardo Lopez-Almaraz, Javier Arzuaga-Mendez, Manuel Ramirez-Orellana, Emily Ashcraft, Daniel Sinnett, Itziar Astigarraga, Idoia Martin-Guerrero, Elixabet Lopez-Lopez

Blood Adv (2025) 9 (24): 6404–6409.

https://doi.org/10.1182/bloodadvances.2025017219

Published: 2025

Includes: Supplemental data

Journal Articles

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major

Pooja Khandelwal, Azada Ibrahimova, Adam Lane, Michael Grimley, Stella M. Davies, Sonata Jodele

Blood Adv (2025) 9 (24): 6370–6379.

https://doi.org/10.1182/bloodadvances.2025017197

Published: 2025

Includes: Supplemental data

Journal Articles

Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma

Blood Adv (2025) 9 (24): 6443–6454.

https://doi.org/10.1182/bloodadvances.2025016827

Published: 2025

Includes: Supplemental data

Journal Articles

Androgen receptor signaling as a new target for intervention in acute myeloid leukemia

Fenghua Qian, Deborpita Sarkar, Brooke E. Arner, Vanessa M. Peduzzi, Yuting Bai, Baiye Ruan, Bei Jia, Hong Zheng, Robert F. Paulson, K. Sandeep Prabhu

Blood Adv (2025) 9 (24): 6326–6339.

https://doi.org/10.1182/bloodadvances.2024012639

Published: 2025

Includes: Supplemental data

Journal Articles

Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe

Blood Adv (2025) 9 (24): 6380–6393.

https://doi.org/10.1182/bloodadvances.2025017081

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Progressive NK-cell dysfunction and ILC imbalance favor immune evasion in multiple myeloma

A new sUSPect in T-ALL risk stratification

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis

SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma

Fifteen years of use of functional imaging in multiple myeloma: where we started and where we are going

Monoclonal gammopathy defines distinct clinical subsets in chronic lymphocytic leukemia across therapeutic eras

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies

Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation

Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL

A novel isoform of tensin-1 promotes actin filament assembly for efficient erythroblast enucleation

Emicizumab in infants: not just cost-effective but mandatory

Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis

Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel

Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcel

USP7 alterations are associated with a poor survival in pediatric T-cell acute lymphoblastic leukemia

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major

Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma

Androgen receptor signaling as a new target for intervention in acute myeloid leukemia

Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only